Caladrius Biosciences, Inc Earning Date (CLBS)

USA |NASDAQ |USD

CLBS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.18 $-0.12 $-0.28
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $0.00 $0.00 $0.00

Caladrius Biosciences, Inc's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

CLBS Earnings Date & History Chart

CLBS Earnings & Revenue Forecast

CLBS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.18 $-0.20 $-0.16
Mar 2022 0 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.55 $-0.55 $-0.55
Dec 2022 2 $-0.44 $-0.44 $-0.44

CLBS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.19 $-0.19 $-0.05
Mar 2022 0 / 0 $0.00 $0.00 $0.00
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.57 $-0.57 $-0.44
Dec 2022 1 / 1 $-0.40 $-0.40 $-0.40

CLBS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Mar 2022 0 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Dec 2022 2 $4.00M $0.00 $8.00M

CLBS Earnings Date & Revenue History

CLBS Earnings History

|
Show More
Show More

CLBS Revenue History

|
Show More
Show More

Caladrius Biosciences, Inc Next Earnings Date & Report

CLBS Next Earnings Date & Report Preview: Dec 2021 (FQ)

CLBS's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 2 analysts, the average EPS estimation for Caladrius Biosciences, Inc's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.20, and a high estimation of $-0.16.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.19, the last 2 month trend is $-0.19, and the 3 month trend is $-0.05.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Caladrius Biosciences, Inc Previous Earnings Dates & Reports

CLBS Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Caladrius Biosciences, Inc's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

CLBS's earnings per share (EPS) was $-0.12, beating the consensus analysts forecast of $-0.13 by 7.69%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 20.00%, and higher than the same period a year before (Sep 2020) by -58.62%.

Revenues were $0.00.

The company reported a net income of $-6.93M.

Free cash flow for the quarter was $-5.04M , compared to $-4.69M last quarter and $-3.52M a year before.

CLBS ended the quarter with $350.00K in total debt, a decrease of -21.35% compared to the previous quarter, and a decrease of -50.70% compared to the same quarter a year before.

CLBS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Caladrius Biosciences, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CLBS's earnings per share (EPS) was $-0.45, beating the consensus analysts forecast of $-0.81 by -44.44% , and higher than the previous year's EPS (Dec 2019) by -75.94%.

Revenues were $0.00.

The company reported a net income of $-8.15M.

Caladrius Biosciences, Inc reported a free cash flow of $-8.84M for its fiscal year, compared to $-18.88M a year ago.

The company ended the fiscal year with $624.00K in total debt, an increase of 76.27% compared to the previous year.